Latest News and Press Releases
Want to stay updated on the latest news?
-
メリーランド州ロックビル, April 19, 2017 (GLOBE NEWSWIRE) -- グローバル･バイオ製薬会社であるスキャンポ･ファーマシューティカルズ（Sucampo Pharmaceuticals, Inc.、以下「スキャンポ」、NASDAQ:...
-
ROCKVILLE, Maryland, April 19, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP) บริษัทชีวเภสัชภัณฑ์ระดับโลก...
-
马里兰州罗克维尔, April 19, 2017 (GLOBE NEWSWIRE) -- 全球生物制药公司Sucampo Pharmaceuticals, Inc. (Sucampo) (纳斯达克股票代码: SCMP)...
-
ROCKVILLE, Md., April 19, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), sebuah perusahaan biofarmasi global, hari ini mengumumkan publikasi studi baru dalam jurnal...
-
馬里蘭州，羅克維爾, April 19, 2017 (GLOBE NEWSWIRE) -- 全球生物製藥公司Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP)今天宣佈，獨立科學期刊發表一項新研究，確認研究中的VTS-270（2-羥丙基-B-環糊精）（HPβCD）產品之獨特組成，為C1型尼曼-匹克氏病(NPC-1)的新型治療方法。NPC-1...
-
ROCKVILLE, Md., April 19, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), una compañía biofarmacéutica global, ha anunciado hoy la publicación de un nuevo estudio en...
-
ROCKVILLE, Maryland, April 19, 2017 (GLOBE NEWSWIRE) -- A Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), empresa biofarmacêutica global, anunciou hoje a publicação de um novo estudo em um...
-
미국 메릴랜드주 록빌, April 19, 2017 (GLOBE NEWSWIRE) -- 글로벌 바이오제약사인 Sucampo Pharmaceuticals(Sucampo)(나스닥 거래명: SCMP)는 과학 학술지를 통해 2-Hydroxypropyl-beta-cyclodextrin (HPβCD) 제품으로 니만-피크병 C1형(NPC-1) 치료용 신약 심사중인...
-
ROCKVILLE, Md., April 19, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), iaitu sebuah syarikat biofarmaseutikal global, hari ini mengumumkan penerbitan kajian baharu...
-
ROCKVILLE, Md., April 18, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the publication of a new study in an...